Simulations Plus Inc SLP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—PULM, SLP, OLN, and HUN
-
Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results
-
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
-
Are ACA, SLP, ALOT, FTHM Obtaining Fair Deals for their Shareholders?
-
Simulations Plus (SLP) Investigation: Investors Who Suffered Losses Encouraged to Contact Johnson Fistel
-
Are ACA, LPRO, SLP, ALOT Obtaining Fair Deals for their Shareholders?
-
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—SLP, FSEA, EQH, and CRBG
-
Simulations Plus (SLP) Investigation: Investors Who Suffered Losses Encouraged to Contact Johnson Fistel
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 20.22M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 20.44
- Price/Sales
- 4.57
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Core
- Total Number of Employees
- 213
- Website
- https://www.simulations-plus.com
Valuation
|
Metric
|
SLP
|
|---|---|
Price/Earnings (Normalized) | 20.44 |
Price/Book Value | 2.76 |
Price/Sales | 4.57 |
Price/Cash Flow | 16.08 |
Price/Earnings
SLP
Financial Strength
|
Metric
|
SLP
|
|---|---|
Quick Ratio | 4.95 |
Current Ratio | 5.54 |
Interest Coverage | — |
Quick Ratio
SLP
Profitability
|
Metric
|
SLP
|
|---|---|
Return on Assets (Normalized) | 8.75% |
Return on Equity (Normalized) | 9.49% |
Return on Invested Capital (Normalized) | 8.88% |
Return on Assets
SLP
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| LOCK|Y$$ychr | LOCK|yX? | $31B | |||
| Pro Medicus Ltd
PMCUF
| — | LOCK|b@$@ | $14B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | LOCK|GT&Ns | $14B | |||
| BrightSpring Health Services Inc
BTSG
| — | LOCK|LqHY | $14B | |||
| Tempus AI Inc Class A common stock
TEM
| — | LOCK|&T! | $10B | |||
| HealthEquity Inc
HQY
| — | LOCK|#zl!$ | $8B | |||
| M3 Inc ADR
MTHRY
| — | LOCK|#FVD | $8B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | LOCK|FWW | $7B | |||
| 10x Genomics Inc Ordinary Shares - Class A
TXG
| — | LOCK|$k | $5B | |||
| Waystar Holding Corp
WAY
| — | LOCK|kVf | $4B |
United States